RAPT: rapt.com Kompaniya qiymatining sof foydaga nisbati
RAPT Therapeutics, Inc. (RAPT) og'zaki allergiya davolash vositalarini ishlab chiqishga ixtisoslashgan. -9.40 indikatori bilan ko'rsatilgan ushbu aksiya kotirovlari grafigi strategik tadqiqot moliyalashtirishi hisobiga balans hisoboti barqarorligini tasdiqlaydi. RAPT Therapeutics, Inc. (RAPT) patogen hujayralarni blokirovka qiluvchi platformani joriy etish orqali onkologiya va yallig'lanish uchun keng qamrovli davolash tizimini yaratmoqda. Sinovlarning FDA tasdig'idan so'ng qayta boshlanishi kutilmoqda, bunda avvalgi risklar investorlar tomonidan allaqachon hisobga olingan.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_RAPT_-_RAPT-Therapeutics-Inc._-_PE-Multiple "RAPT: RAPT Therapeutics, Inc. Biznesning o‘zini qoplash muddati 04.07.2022 - 14.03.2026 | 👁️GURU.Markets👁️")
RAPT Therapeutics, Inc. (RAPT) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati RAPT Therapeutics, Inc.|RAPT - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati rapt.com|RAPT - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati RAPT Therapeutics, Inc.|RAPT - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz RAPT Therapeutics|Oraliq qoplash koeffitsiyenti rapt.com
- foyda va bozor multiplikatorlari tafsilotlari:
RAPT - Sof foyda|Prognoz qilingan kelajakdagi foyda RAPT Therapeutics, Inc.|RAPT - Narxning foydaga nisbati|Narxning kutilayotgan foydaga nisbati RAPT Therapeutics Inc.|RAPT - Narx-foyda va o‘sish multiplikatori|Korxona qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati koeffitsiyenti RAPT Therapeutics, Inc.|RAPT - Eskirish chegirilmasdan oldingi operatsion foyda|Sirpanuvchi yil uchun bir aksiya uchun foyda RAPT Therapeutics|RAPT - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sish sur'ati rapt.com|RAPT - Joriy yilda foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi RAPT Therapeutics, Inc.
- realizatsiya hajmi va tushum ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:RAPT Therapeutics Inc. RAPT
Fundamental aktivlarni tanlash bozor kapitalizatsiyasi va sof foyda o'rtasidagi nisbatning qat'iy tahlilini talab qiladi. P/E ko'rsatkichi bir dollar foydaning tannarxini o'lchab, investitsiya jozibadorligini va haddan tashqari ko'p to'lov qilish xavfini aniqlaydi. Virtual R&D modeliga ega bo'lgan RAPT Therapeutics, Inc. (RAPT) uchun ushbu metrika klinik sinovlar autsorsing samaradorligining bozor tomonidan baholanishini aks ettiradi. Emitentning P/E grafigi investorlarga spekulyativ o'sishni haqiqiy biznesning mustahkamlanishidan ajratish imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|ABCL - Narxning foydaga nisbati|Kompaniya qiymatining sof foydaga nisbati TRML (Tourmaline)|PGEN: P/E multiplikatori|pharming.com (PHAR) - P/E multiplikatori|Narxning foydaga nisbati Nektar Therapeutics Inc.|Upstream Bio, Inc. - Kapitalizatsiyaning sof foydaga nisbati|Narx-foyda koeffitsiyenti ZBIO (Zenas Biopharma, Inc.)|Bozor narxining sof foydaga nisbati IMNM|Gossamer Bio, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati KALV|SEPN: Narx-foyda koeffitsiyenti|Pieris Pharma - Bozor narxining sof foydaga nisbati|SVRA: P/E multiplikatori|Rigel Corp - Kompaniya qiymatining sof foydaga nisbati|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati astriatx.com ATXS|Narxning foydaga nisbati enGene (ENGN)|JBIO (aerovatetx.com) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ACRS (Aclaris)|P/E multiplikatori Kyverna Therapeutics, Inc KYTX|TLSA - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati CABA|VTYX: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Theratechnologies, Inc. (THTX)|Narx-foyda koeffitsiyenti AVTX|P/E multiplikatori Eledon Pharmaceuticals, Inc|Narx-foyda koeffitsiyenti AGEN (Agenus)|Bozor narxining sof foydaga nisbati CLYM|P/E multiplikatori ZURA (Zura Bio)|Biznesning o‘zini qoplash muddati aTyr Pharma Inc (ATYR)|Adagene Corp - P/E multiplikatori|ImageneBio Inc (IMA) - Narx-foyda koeffitsiyenti|shattucklabs.com (STTK) - Narxning foydaga nisbati|EQ - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti CNTB|IMUX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ATRA|Biznesning o‘zini qoplash muddati inflarx.de|Narxning foydaga nisbati X4 Pharmaceuticals XFOR|ACET: Narx-foyda multiplikatori|Celularity Corp - P/E multiplikatori|INmune Bio Inc (INMB) - Narx-foyda koeffitsiyenti|BRNS (Barinthus Bio) - Narx-foyda koeffitsiyenti|KZR - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati SAB Biotherapeutics|AKTX: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ENLV|P/E multiplikatori q32bio.com (QTTB)|Narxning foydaga nisbati GeoVax Labs Inc GOVX|EDSA (Edesa Biotech Corp) - Kapitalizatsiyaning sof foydaga nisbati|IBIO: Narx-foyda koeffitsiyenti|Carisma Therapeutics - Bozor narxining sof foydaga nisbati|XTL Biopharmaceuticals Ltd. (XTLB) - Narxning foydaga nisbati|Kapitalizatsiyaning sof foydaga nisbati BOLT (Bolt Biotherapeutics, Inc.)|HCWB (HCW Biologics, Inc.) - P/E multiplikatori|APVO: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AIM|P/E multiplikatori aditxt.com (ADTX)|Narxning foydaga nisbati GRI Bio GRI|Kompaniya qiymatining sof foydaga nisbati XRTX|HIND - Narxning foydaga nisbati|Revelation Biosciences Corp (REVB) - Narx-foyda koeffitsiyenti|INDP: P/E multiplikatori|scinai.com (SCNI) - P/E multiplikatori|Narx-foyda koeffitsiyenti CALI|AFMD: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ALLK|Biznesning o‘zini qoplash muddati hookipapharma.com|Narxning foydaga nisbati IGM Biosciences IGMS|ITOS - Narx-foyda koeffitsiyenti|OCEA - Narxning foydaga nisbati|TC BioPharm (Holdings) Plc (TCBP) - Narx-foyda koeffitsiyenti|THRD (Third Harmonic Bio, Inc) - Narx-foyda koeffitsiyenti
